We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Alcon Asks FDA for Strict Standards for Durezol, Ciprodex Generics
Alcon Asks FDA for Strict Standards for Durezol, Ciprodex Generics
Alcon Pharmaceuticals is asking the FDA to apply stricter requirements on bioequivalence studies intended to supplement applications for Durezol and Ciprodex generics.